Oxiranecarboxylic acids for the treatment of diabetes
US6670481B2 · kind B2 · utility
1Cited by
7References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 18, 2002 |
| Grant date | Dec 30, 2003 |
| Priority date | — |
| Expiry date | Jul 6, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel arylalkyl- or aryloxyalkyl-substituted oxiranecarboxylic acids of the general formula I: in which Ar, R3, Y and n are as defined in the description, and also to medicaments comprising them and to their use for the treatment and prophylaxis of the disorders mentioned in claim 4 which are caused by disturbances of glucose and/or lipid metabolism, such as, for example, diabetes type 2 and other insulin-resistant conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.